Clinical Trial Update: Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating the efficacy of a buprenorphine and extended-release naltrexone combination for relapse prevention in opioid use disorder, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)
• extended-release naltrexone (naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 2, Phase 3 | Status: RECRUITING